Alkem Laboratories Ltd
NSE:ALKEM

Watchlist Manager
Alkem Laboratories Ltd Logo
Alkem Laboratories Ltd
NSE:ALKEM
Watchlist
Price: 5 406.3 INR Market Closed
Market Cap: 646.4B INR
Have any thoughts about
Alkem Laboratories Ltd?
Write Note

Alkem Laboratories Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Alkem Laboratories Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Alkem Laboratories Ltd
NSE:ALKEM
Other Long-Term Assets
â‚ą15.3B
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Long-Term Assets
â‚ą18.6B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Long-Term Assets
â‚ą8.3B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
19%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Long-Term Assets
â‚ą46.8B
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
13%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Long-Term Assets
â‚ą6.1B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
15%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Long-Term Assets
â‚ą1.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Alkem Laboratories Ltd
Glance View

Market Cap
646.4B INR
Industry
Pharmaceuticals

Alkem Laboratories Ltd., founded in 1973, has emerged as a significant player in India's pharmaceutical landscape, deftly combining innovation with a robust distribution network. Anchored in Mumbai, Alkem began as a modest venture but quickly evolved into a powerhouse, renowned for manufacturing a broad spectrum of branded generics, over-the-counter products, and active pharmaceutical ingredients (APIs). The company's success lies in its ability to cater to both domestic and international markets, primarily thriving on the ever-increasing demand for affordable healthcare solutions. Its formidable market presence in India is supported by a strong sales force and an extensive distribution network, ensuring its therapies reach even the most remote corners of the country. Internationally, Alkem has carved a niche for itself, with the United States being one of its major export markets. It strategically entered this competitive arena, building a portfolio of ANDAs (Abbreviated New Drug Applications) that allowed it to provide lower-cost alternatives to big pharma's patented drugs. This not only fueled its revenue growth but also fortified its standing as a go-to source for quality generics. Alkem's research and development efforts underpin its commitment to healthcare innovation, as it constantly seeks to expand its therapeutic repertoire. By consistently focusing on quality, affordability, and resourceful adaptation to global healthcare needs, Alkem Laboratories Ltd. has managed to script a growth story that is both impressive and sustainable.

ALKEM Intrinsic Value
3 919.37 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Alkem Laboratories Ltd's Other Long-Term Assets?
Other Long-Term Assets
15.3B INR

Based on the financial report for Jun 30, 2024, Alkem Laboratories Ltd's Other Long-Term Assets amounts to 15.3B INR.

What is Alkem Laboratories Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
15%

Over the last year, the Other Long-Term Assets growth was 13%. The average annual Other Long-Term Assets growth rates for Alkem Laboratories Ltd have been 10% over the past three years , 15% over the past five years .

Back to Top